Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy
Scigliano, G.; Musicco, M.; Soliveri, P.; Girotti, F.; Giovannini, P.; Fetoni, V.; Caraceni, T.
Advances in Neurology 69: 305-309
1996
ISSN/ISBN: 0091-3952 PMID: 8615143 Document Number: 466870
Document emailed within 1 workday
Related Documents
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Zhao, Z.-s.; Ru, G.-q.; Ma, J. 2004: MRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma Zhonghua Zhong Liu Za Zhi 26(11): 673-677
Smolentseva, I.G.; Chupina, L.P.; Amosova, N.A.; Krivonos, O.V. 2014: Clinical evaluation of Parkinson's disease progression Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(6 Part 2): 36-40
Ahlskog, J.Eric.; Maraganore, D.M.; Uitti, R.J.; Uhl, G.R. 2002: Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease JAMA 288(3): 311; Author Reply 312-3
Albin, R.L.; Nichols, T.E.; Frey, K.A. 2002: Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease JAMA 288(3): 311
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Müller-Bühl, U.; Diehm, C.; Kübler, W.; Schettler, G. 1988: Coronary and peripheral arterial occlusive disease. Concomitant prevalence and risk factors Versicherungsmedizin 40(6): 161-163
Jagadeesan, A.J.; Murugesan, R.; Vimala Devi, S.; Meera, M.; Madhumala, G.; Vishwanathan Padmaja, M.; Ramesh, A.; Banerjee, A.; Sushmitha, S.; Khokhlov, A.N.; Marotta, F.; Pathak, S. 2017: Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review Acta Bio-Medica: Atenei Parmensis 88(3): 249-262
Sanchez Rodriguez, J.L. 2002: Neuropsychological deficit in Parkinson's disease. its relation with clinical variables Revista de Neurologia 35(4): 310-317
Selby, G. 1984: The Graeme Robertson memorial lecture, 1983. The long-term prognosis of Parkinson's disease Clinical and Experimental Neurology 20: 1-25
1999: Peripheral COMT-inhibition with Entacapon. Optimal therapy of Parkinson disease Der Nervenarzt 70(6 Suppl): 1-8
Takamatsu, S.; Noguchi, N.; Kudoh, A.; Nakamura, N.; Kawamura, T.; Teramoto, K.; Igari, T.; Arii, S. 2008: Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma Hepato-Gastroenterology 55(82-83): 609-614
Peñagarícano, J.é A.; Linskey, M.E.; Ratanatharathorn, V. 2004: Accelerated cerebral vasculopathy after radiation therapy to the brain Neurology India 52(4): 482-486
Bogdanov, R.R.; Manannikova, E.I.; Abrabenko, A.S.; Maratkanova, T.V.; Kotov, S.V. 2013: Morphometric parameters of the neurodegenerative process in Parkinson's disease and chronic cerebral ischemia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10): 40-44
Chovancová, Z.; Kanovský, P.; Nestrasil, I.; Dufek, J.; Nevrlý, M.; Otruba, P. 2008: Peripheral nerve injury and the degree of motor involvement in Parkinson's disease: a correlation study Casopis Lekaru Ceskych 147(4): 211-214
Banach, T.; Zurowski, D.; Gil, K.; Krygowska-Wajs, A.; Marszałek, A.; Thor, P.J. 2006: Peripheral mechanisms of intestinal dysmotility in rats with salsolinol induced experimental Parkinson's disease Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 57(2): 291-300
Welten, G.M.J.M.; Schouten, O.; Chonchol, M.; Hoeks, S.E.; Bax, J.J.; Van Domburg, R.T.; Poldermans, D. 2009: Prognosis of patients with peripheral arterial disease Journal of Cardiovascular Surgery 50(1): 109-121
Hernández Cañete, C.M.; Tejidor Fernández, J.; Segura Macias, R.; Pila Pérez, R. 1991: Diabetic vasculopathy, its relation to hypoglycemic agent use, the time of evolution and patient age Angiologia 43(6): 235-240
Fischer, P.A. 1987: Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus) Advances in Neurology 45: 235-238